Analyst Ratings for Menlo Therapeutics (MNLO)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/21/2020 | Northland » Updated 6/1/2020 |
Tim Chiang | New Coverage | Outperform (N/A) |
6.00 (3.50) |
1.97 (1.35) |
-31.47% | Details |
| 3/25/2020 | Barclays » Updated 5/13/2020 |
Balaji Prasad | New Coverage | Overweight (N/A) |
3.00 (2.00) |
3.13 (1.35) |
-56.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
